In this Episode, Dr. Scott T. Micek from Barnes-Jewish Hospital in St. Louis, Missouri provides insights on when an alternative agent to vancomycin should be considered for MRSA infections.

When should an alternative agent to vancomycin be considered for MRSA infections?

Designed to clarify persistent issues in serious MRSA infections that pose 
a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.

Education

Designed to clarify persistent issues in serious MRSA infections that pose a threat to patient safety and add to the healthcare burden. Experts answer frequently asked questions and share their own clinical experience. This activity consists of 20 episodes that will be released weekly beginning October 4, 2010.

Share When should an alternative agent to vancomycin be considered for MRSA infections?

Sign up to save your podcasts

When should an alternative agent to vancomycin be considered for MRSA infections?

When should an alternative agent to vancomycin be considered for MRSA infections?

More shows like Let's Talk MRSA: 20 Frequently Asked Questions

ASHPOfficial